Filter

Refine by date

—

Refine by collections

Refine by access

  • Print
  • Save

Search Results

You are looking at 1 - 2 of 2 items for :

  • Gut microbiome special collection x
  • Refine by access: All content x
Clear All
Fabio Arturo Iannotti Institute of Biomolecular Chemistry, Consiglio Nazionale delle Ricerche, Pozzuoli, Campania, Italy

Search for other papers by Fabio Arturo Iannotti in
Google Scholar
PubMed Close
and
Vincenzo Di Marzo Director, Joint International Research Unit for the Chemical and Biomolecular Study of the Microbiome in Metabolic Health and Nutrition (JIRU-MicroMeNu) between the Consiglio Nazionale delle Ricerche (CNR, Institute of Biomolecular Chemistry) and Université Laval, Naples, Campania, Italy
Canada Excellence Research Chair on the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Department of Medicine, Faculty of Medicine and School of Nutrition, Faculty of Agricultural and Food Sciences, CRIUCPQ, INAF and Centre NUTRISS, Université Laval, Québec City, Canada

Search for other papers by Vincenzo Di Marzo in
Google Scholar
PubMed Close

-oleoyl- and N -arachidonoyl-dopamine, which instead activate CB1 and/or TRPV1 ( Bisogno et al. 2000 , Chu et al. 2003 ), and were recently shown to also act as inverse agonists at GPR6 ( Shrader & Song 2020 ). Additionally, the enzymatic oxidation

Article Type:
Review Article
Collections:
Gut microbiome special collection
DOI:
https://doi.org/10.1530/JOE-20-0444
Volume/Issue:
Volume 248: Issue 2
Free access
Nicole G Barra Department of Biochemistry and Biomedical Sciences, Department of Biochemistry and Biomedical Sciences, Farncombe Family Digestive Health Research Institute, Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada

Search for other papers by Nicole G Barra in
Google Scholar
PubMed Close
,
Fernando F Anhê Department of Biochemistry and Biomedical Sciences, Department of Biochemistry and Biomedical Sciences, Farncombe Family Digestive Health Research Institute, Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada

Search for other papers by Fernando F Anhê in
Google Scholar
PubMed Close
,
Joseph F Cavallari Department of Biochemistry and Biomedical Sciences, Department of Biochemistry and Biomedical Sciences, Farncombe Family Digestive Health Research Institute, Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada

Search for other papers by Joseph F Cavallari in
Google Scholar
PubMed Close
,
Anita M Singh Department of Biochemistry and Biomedical Sciences, Department of Biochemistry and Biomedical Sciences, Farncombe Family Digestive Health Research Institute, Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada

Search for other papers by Anita M Singh in
Google Scholar
PubMed Close
,
Darryl Y Chan Department of Biochemistry and Biomedical Sciences, Department of Biochemistry and Biomedical Sciences, Farncombe Family Digestive Health Research Institute, Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada

Search for other papers by Darryl Y Chan in
Google Scholar
PubMed Close
, and
Jonathan D Schertzer Department of Biochemistry and Biomedical Sciences, Department of Biochemistry and Biomedical Sciences, Farncombe Family Digestive Health Research Institute, Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada

Search for other papers by Jonathan D Schertzer in
Google Scholar
PubMed Close

. This species requires molybdenum for dopamine dehydroxylation, which metabolizes the medication Levodopa used in Parkinson’s disease, preventing dopamine from crossing the blood-brain barrier ( Maini Rekdal et al. 2019 ). Microbial molybdenum

Article Type:
Review Article
Collections:
Gut microbiome special collection, Top-cited articles of 2023
DOI:
https://doi.org/10.1530/JOE-21-0081
Volume/Issue:
Volume 250: Issue 2
Free access